Investor actively backing innovative startups and growth-stage companies across various industries and funding rounds.
Verified emails & LinkedIn for founders across this portfolio.
Cabaletta Bio has adapted clinically-validated and FDA-approved CAR T cell technology to target B cell-mediated autoimmune diseases.
Iterative Health develops technology that can benefit patients anywhere, regardless of socioeconomic or geographic barriers.
Incyclix Bio develops small molecule inhibitors of CDKs for the treatment of advanced and resistant cancers.
Crossbow Therapeutics is a biotech company that develops targeted therapies to address cancer antigens.
Juvena Therapeutics develops tissue-restorative biologics to address chronic muscle and age-related conditions.
Recludix pharma is a developing platform to treat cancer patients.
InduPro deevlops proximity-based protein therapeutics that modulate cell-surface protein interactions to treat disease.
Terns Pharmaceuticals develops small-molecule therapies for chronic diseases including cancer, metabolic disorders, and liver conditions.
Sanegene Bio develops an RNAi drug discovery platform designed for unmet clinical needs.
Excelsior Sciences applies AI and automated chemistry to simplify small-molecule discovery and accelerate overall drug development.
Gate Bioscience is a biotechnology company that specializes in a small molecule modality to treat biology’s intractable diseases.
NextCure is a biopharmaceutical company focused on discovering and developing next generation immuno-oncology-based drugs.
Affinia Therapeutics is a biotechnology company developing transformative AAV gene therapies for people with rare and prevalent diseases.
Trogenix is a biotech company that develops precision cancer treatments that selectively target diseased cell states and behaviour.
Volastra Therapeutics is a biotechnology company developing novel therapies for the treatment of metastatic cancers.
Dualitas Therapeutics is leading the way in bispecific antibody treatments for inflammatory and immunological (I&I) disorders
Synapse Energy Economics is a consulting firm providing economic and policy analysis for the electric power sector.
HAYA Therapeutics is a biotechnology company developing precision RNA-guided medicines that target the dark genome.
Auron aims to cure cancer therapeutics from cell killing to transformation of malignant cells into more normal functioning cells.
Signify Bio is a biotechnology company harnessing the human body for the production of in situ protein therapeutics.
Syndeio Biosciences is a newly launched biotech company pioneering precision neurotherapeutics.
Therini Bio specializes in fibrin-targeting therapies to treat inflammatory neurological and retinal diseases.
Seraxis is a privately owned biotechnology company.
Stylus Medicine is on a quest to create disease-treating agents for the next generation based on the groundbreaking work of its founders.
Eli Lilly has invested in 169 companies tracked in our database. The portfolio spans multiple industries and funding stages, from seed-stage startups to late-stage companies.
Eli Lilly's top investment sectors include Biotechnology, Health Care, Medical, Therapeutics, Life Science. The firm invests across 18 different industry categories.
Among tracked funding rounds, Avidity Biosciences received $690.0M in a Post-IPO Equity round. Eli Lilly's total known invested capital is $11.1B.
Eli Lilly's average investment size is $69.2M across its portfolio of 169 companies.
Recent Eli Lilly portfolio additions include Cabaletta Bio, Iterative Health, Incyclix Bio, Crossbow Therapeutics, Juvena Therapeutics. These companies were founded in 2020 or later.